comparemela.com
Home
Live Updates
Nina Dvorina - Breaking News
Pages:
Nina Dvorina News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technology
SAN JOSE, Calif., June 21, 2022 /PRNewswire/ Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and preve.
Nina dvorina
Suparna mazumder
Mike catelani
Vincentk tuohy
Eric ribner
Valerie swank
Amit kumar
Justinm johnson
Molgenie gmb
Lifesci advisors
National cancer institute
Company contact
Moffitt cancer center
Prnewswire anixa biosciences inc
Anixa biosciences inc
Experimental vaccine research
vimarsana © 2020. All Rights Reserved.